News

36% of clinical trials launched in Spain correspond to initial phases of research – these phases are the most complex, but are also the most essential to trial potentially effective molecules.

MD Anderson Madrid – Hospiten currently has eight phase I clinical trials open to recruitment, but hopes to close the year with 15-20 phase I trials running

Although the COVID-19 pandemic has made the public more aware of what a clinical trial is, the reality is that there is still they do not know, above all, about the time required by research.

Al ser un centro dedicado al abordaje de pacientes oncológicos, MD Anderson Madrid – Hospiten ha acogido un número importante de cirugías oncológicas de pacientes procedentes de otros hospitales de la Comunidad de Madrid

La colaboración de MD Anderson Madrid – Hospiten con la iniciativa “Acortando la distancia” ha permitido que las personas ingresadas hayan podido disponer de móviles y tabletas para comunicarse con sus familiares

People who live in the same household with these patients must reduce contact with them, clean common areas often, disinfect the shopping before the patient touches these items and use masks inside the home

Although it is recommended that non-urgent bone marrow transplants be postponed, MD Anderson Madrid – Hospiten has launched a protocol to guarantee the safety of those who need transplants without delay

MD Anderson Madrid – Hospiten se une también al movimiento solidario de enviar cartas de ánimo a los pacientes y personal sanitario de los hospitales de la Comunidad de Madrid. 

Debido a la especial protección que requieren estos pacientes y a su mayor riesgo potencial en caso de infección por coronavirus, el centro está acogiendo pacientes oncológicos de otros hospitales de la Comunidad de Madrid, en el marco del estado de alarma decretado en España por la pandemia por COVID-19

This decision is accordance with the guidelines published by of the Ministry of Health, the Ministry of Health of the Autonomous Regions and the Medical Society.

With more than ten years' experience in treating patients with digestive tumours in the Fundación Jiménez Díaz, Dr José Ignacio Martín Valadés joins the MD Anderson Cancer Center Madrid – Hospiten as the new head of the Digestive Tumours Section in the Medical Oncology Service.

After more than 15 years of experience in autologous and allogeneic transplants, MD Anderson Cancer Madrid has launched a new Haematopoietic Transplant Unit with a view to enhancing and developing the transplant programme and offering CAR-T therapy.

22% of people diagnosed with cancer in Spain have a rare tumour, according to data from the Spanish Orphan and Infrequent Tumours Group (GETHI). In these cases, as with other rare diseases, the main problems are delayed diagnosis, reduced availability of therapeutic options and, above all, the difficulty of finding professionals who are experts in a disease that only affects a small part of the population.

On the occasion of World Cancer Day, MD Anderson Cancer Center Madrid – Hospiten and Cigna España have presented ‘Cancer in the company: Practical Notes for Human Resources,’ a guide that covers a wide range of recommendations to support organisations in the development of comprehensive cancer management policies.